Wire Stories
-
647Laurentian Bank Financial Group reports second quarter 2021 results
The financial information reported herein is based on the condensed interim consolidated (unaudited) information for the three-month period ended April�30, 2021, and...
-
531
Investigation Report on China’s Osimertinib Market 2021-2025: A Small Molecule Targeted Anti-tumor Drug Used to Treat Non-small Cell Lung Cancer (NSCLC) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Osimertinib Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Osimertinib is a small molecule targeted...
-
637
World Health Organization Authorizes SINOVAC�s CoronaVac� for Emergency Use
BEIJING–(BUSINESS WIRE)–SINOVAC Biotech Ltd. (�SINOVAC� or the �Company�) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that CoronaVac�,...
-
603
Investigation Report on China’s Osimertinib Market 2021-2025: A Small Molecule Targeted Anti-tumor Drug Used to Treat Non-small Cell Lung Cancer (NSCLC) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Investigation Report on China’s Osimertinib Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering. Osimertinib is a small molecule targeted...
-
572
Aragen (Formerly GVK BIO) to Partner With Global Biopharma With a Renewed Brand Promise
HYDERABAD, India–(BUSINESS WIRE)–#Aragen–Aragen Life Sciences (Aragen), formerly known as GVK Biosciences and a leading contract research, development and manufacturing organization, officially marked...
-
666
Aragen (Formerly GVK BIO) to Partner With Global Biopharma With a Renewed Brand Promise
HYDERABAD, India–(BUSINESS WIRE)–#Aragen–Aragen Life Sciences (Aragen), formerly known as GVK Biosciences and a leading contract research, development and manufacturing organization, officially marked...
-
599
World Health Organization Authorizes SINOVAC�s CoronaVac� for Emergency Use
BEIJING–(BUSINESS WIRE)–SINOVAC Biotech Ltd. (�SINOVAC� or the �Company�) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that CoronaVac�,...
-
713
Lyra Therapeutics and LianBio Announce Strategic Partnership and Exclusive License Agreement to Develop and Commercialize LYR-210 in Greater China and Other Asian Markets
Partnership opens expanded opportunity for LYR-210 to address chronic rhinosinusitis, a disease affecting approximately 88 million adults in China WATERTOWN, Mass. &...
-
757
Lyra Therapeutics and LianBio Announce Strategic Partnership and Exclusive License Agreement to Develop and Commercialize LYR-210 in Greater China and Other Asian Markets
Partnership opens expanded opportunity for LYR-210 to address chronic rhinosinusitis, a disease affecting approximately 88 million adults in China WATERTOWN, Mass. &...
-
569
Employers must better understand their people to improve staff retention
Employers should use staff assessments to make better-informed people decisions and improve employee retention TRUMBULL, Conn.–(BUSINESS WIRE)–#HR–Staff retention has become a key...
